US BioTek Laboratories Listed by killsec Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

People who have used laboratory testing services may now face questions about whether their personal or medical information has been taken. On April 2, 2025, US BioTek Laboratories appeared on a ransomware leak site, raising the possibility that internal files containing sensitive records were copied during an attack. The number of people affected remains unknown, and public detail about what exactly left the organisation is limited, yet the listing alone is enough to put patients, employees and partners on alert.

Ransomware groups often use such listings to pressure victims into paying. Until more is confirmed, anyone who has interacted with the laboratory has reason to treat the claim seriously and to watch for signs of misuse of their data.

Inside the incident

US BioTek Laboratories was listed on the killsec ransomware leak site on April 2, 2025. According to the reported summary, the group claims to have stolen internal data and to have exfiltrated internal files in a ransomware attack. No further technical details have been made public. The scale of the incident, the precise method of intrusion, the volume of data taken, and any ransom demand remain undisclosed. The number of people whose information may be involved is also unknown. What is established is only the leak-site listing itself and the group’s assertion that internal files were removed.

At this stage the listing stands as an unverified claim by the threat actor. No independent confirmation of the theft or of any subsequent data release has been included in the available facts.

Who is killsec?

Killsec is a ransomware operation that has been active in recent years and is known for double-extortion tactics. The group typically encrypts systems and simultaneously steals data, then threatens to publish the material on a dedicated leak site if a ransom is not paid. Like other ransomware crews, killsec has listed organisations across healthcare, manufacturing and professional services, using the public threat of disclosure as leverage. Public reporting has documented its use of common ransomware techniques, including initial access through compromised credentials or vulnerabilities, followed by lateral movement and data exfiltration before encryption.

In this case the group claims to have stolen internal data from US BioTek Laboratories. Beyond that assertion, no additional statements specific to this victim have been provided in the facts. The listing should therefore be understood as the group’s own claim rather than an independently verified event.

Who is US BioTek Laboratories?

US BioTek Laboratories is a clinical laboratory that provides diagnostic testing services. Organisations of this type routinely handle patient specimens, test results, ordering physician information, and associated administrative records. They operate in a regulated healthcare environment where protected health information and other personal data are central to daily work. A breach involving such a laboratory is consequential because the data it holds can include medical histories, contact details and identifiers that remain sensitive long after a single test is completed.

Public background on the sector shows that laboratories often maintain both clinical systems and internal business files. Any unauthorised access therefore carries implications for patient privacy, regulatory obligations and the organisation’s ability to continue operations without disruption.

What was likely exposed

The facts state that internal files were exfiltrated in a ransomware attack and that the group claims to have stolen internal data. No specific data types beyond that description have been named. Exact contents remain unconfirmed.

Laboratories of this kind typically hold patient demographic information, test orders and results, insurance or billing details, employee records, and internal operational documents. Whether any of those categories were among the files taken has not been disclosed. Until further information is released, it is not possible to state with certainty what was exposed.

What's at stake

For individuals, the primary risk is the potential misuse of personal or health-related information. Even if only internal files were taken, those files could contain enough detail to enable identity theft, targeted phishing, or medical fraud. People whose data may be involved may later receive unsolicited contacts that appear to come from legitimate healthcare sources. Monitoring financial and medical accounts becomes a practical necessity.

For the organisation, the stakes include regulatory scrutiny under healthcare privacy rules, possible notification duties, operational disruption from any encryption that accompanied the exfiltration, and reputational damage. The absence of confirmed numbers does not reduce the need for careful response; it simply means the full scope is still unknown.

Were you affected?

If you have used US BioTek Laboratories for testing or have been an employee or business partner, treat the claim as a prompt to act. Review recent account statements and medical correspondence for unusual activity. Consider placing fraud alerts with credit bureaus and enabling multi-factor authentication on email and healthcare portals. Change passwords that may have been reused across services. Readers can also run a free exposure scan of their email address to check whether their information has already surfaced in known breach data sets. Official notifications, if any are required, will come directly from the organisation or regulators; until then, vigilance is the most useful step available.

AICompiled with AI assistance from public sources and published under our editorial standards.